We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.47B
AUM Growth
+$309M
Cap. Flow
+$259M
Cap. Flow %
17.55%
Top 10 Hldgs %
27.29%
Holding
179
New
33
Increased
51
Reduced
54
Closed
39

Top Buys

Rank Stock Value
1
APP icon
Applovin
APP
+$58.8M
2
LYFT icon
Lyft
LYFT
+$27.4M
3
CLVT icon
Clarivate
CLVT
+$26.3M
4
FTDR icon
Frontdoor
FTDR
+$24.5M
5
CRM icon
Salesforce
CRM
+$23.3M

Sector Composition

Rank Sector Weight
1 Technology 31.82%
2 Consumer Discretionary 14.98%
3 Communication Services 13.53%
4 Healthcare 8.23%
5 Industrials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLF icon
1
PUT
State Street Financial Select Sector SPDR ETF
XLF
$57.4B
$80.4M 5.45%
+2,350,000
New +$79.5M
APP icon
2
Applovin
APP
$140B
$46.1M 3.13%
4,376,277
+4,006,911
+1,085% +$58.8M
FTDR icon
3
Frontdoor
FTDR
$5.22B
$40.1M 2.72%
1,929,757
+1,116,578
+137% +$24.5M
IPGP icon
4
IPG Photonics
IPGP
$3.57B
$37.4M 2.54%
394,722
+111,561
+39% +$10M
LYFT icon
5
Lyft
LYFT
$5.87B
$35.1M 2.38%
3,180,679
+2,272,572
+250% +$27.4M
EBAY icon
6
eBay
EBAY
$52.1B
$34.5M 2.34%
832,284
+60,545
+8% +$2.51M
T icon
7
AT&T
T
$169B
$33.6M 2.28%
1,826,488
-29,032
-2% -$520K
CMCSA icon
8
Comcast
CMCSA
$85.8B
$32.8M 2.23%
938,031
-19,154
-2% -$634K
DBX icon
9
Dropbox
DBX
$7.48B
$32.7M 2.22%
1,462,865
+56,209
+4% +$1.24M
FLEX icon
10
Flex
FLEX
$41.5B
$29.5M 2%
1,822,702
-411,175
-18% -$6.17M
SSNC icon
11
SS&C Technologies
SSNC
$18.8B
$29.4M 1.99%
564,143
+193,464
+52% +$9.81M
CRM icon
12
Salesforce
CRM
$149B
$28.3M 1.92%
213,467
+159,680
+297% +$23.3M
WBD icon
13
Warner Bros
WBD
$64.2B
$27.8M 1.89%
2,932,121
+867,561
+42% +$9.79M
RAMP icon
14
LiveRamp
RAMP
$2.29B
$26.8M 1.82%
1,141,825
+1,011,924
+779% +$20.4M
VNT icon
15
Vontier
VNT
$4.62B
$25M 1.7%
1,292,918
+319,565
+33% +$5.99M
ZM icon
16
Zoom
ZM
$26.8B
$23.9M 1.62%
352,332
+117,981
+50% +$8.96M
HBI
17
DELISTED
Hanesbrands
HBI
$23.5M 1.6%
3,700,968
+1,269,850
+52% +$8.72M
CLVT icon
18
Clarivate
CLVT
$1.53B
$23.4M 1.59%
+2,805,166
New +$26.3M
VTRS icon
19
Viatris
VTRS
$20.8B
$21.9M 1.49%
1,967,472
+914,106
+87% +$9.55M
LEVI icon
20
Levi Strauss
LEVI
$9.8B
$19.6M 1.33%
1,262,747
+314,942
+33% +$4.89M
UHS icon
21
Universal Health Services
UHS
$10.1B
$19.4M 1.31%
137,491
-189,246
-58% -$22.3M
CTSH icon
22
Cognizant
CTSH
$23.8B
$18.8M 1.28%
328,631
+228,451
+228% +$13.4M
VRN
23
DELISTED
Veren
VRN
$17.3M 1.18%
2,422,370
-729,125
-23% -$5.41M
WEX icon
24
WEX
WEX
$6.23B
$16.8M 1.14%
102,909
-5,575
-5% -$868K
CLS icon
25
Celestica
CLS
$40.3B
$16.4M 1.11%
1,452,290
-29,791
-2% -$313K

Similar funds

Invenomic Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Invenomic Capital Management held 179 positions worth $1.47B, up 27% from $1.16B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Invenomic Capital Management deployed $259M of net new capital in Q4 2022, opening 33 new positions and adding to 51 existing holdings. Its largest new stake was Clarivate: 2,805,166 shares worth $23.4M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Universal Health Services, an estimated $22.3M trimmed.

  • Invenomic Capital Management's largest Q4 2022 buy was Clarivate: 2,805,166 shares worth $23.4M.
  • Invenomic Capital Management added most to Applovin in Q4 2022, an estimated $58.8M increase.
  • Invenomic Capital Management's biggest Q4 2022 reduction was Universal Health Services, cutting an estimated $22.3M.
  • Invenomic Capital Management fully exited Cisco in Q4 2022, selling an estimated $27.1M.
  • Invenomic Capital Management's ten largest holdings make up 27% of its $1.47B portfolio in Q4 2022.
  • Invenomic Capital Management opened 33 new positions and closed 39 in Q4 2022.
  • Invenomic Capital Management's portfolio value rose 27% quarter-over-quarter to $1.47B.

Based on Invenomic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.